Rhythm Pharmaceuticals buy JPMorgan Chase & Co.
Start price
27.07.26
/
50%
€90.00
Target price
27.07.27
€127.17
Performance (%)
1.67%
Price
08:32
?
Summary
This prediction is currently active. The BUY prediction by JPMorgan_Chase___Co_ shows slight gains of 1.67%. This prediction currently runs until 27.07.27. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Rhythm Pharmaceuticals | 1.67% |
| iShares Core DAX® | 1.014% |
| iShares Nasdaq 100 | -6.470% |
| iShares Nikkei 225® | -6.517% |
| iShares S&P 500 | -2.721% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals (RYTM) is now covered by JPMorgan Chase & Co.. They set an "overweight" rating and a $145.00 price target on the stock.
Ratings data for RYTM provided by MarketBeat

